Bio-Techne (TECH) Gross Margin (2009 - 2026)

Bio-Techne (TECH) recorded quarterly Gross Margin of 66.88% in Q1 2026, up 3.46% quarter-over-quarter from 64.65% in Q4 2025, and down 97.0% on a YoY basis from 2229.48% in Q1 2025.

Bio-Techne (TECH) Gross Margin (2009 - 2026) Analysis & Trends

Bio-Techne's Gross Margin history runs 18 years deep, the most recent figure standing at 66.88% for Q1 2026.

  • In Q1 2026, Gross Margin fell 97.0% year-over-year to 66.88%; the TTM figure through Mar 2026 stood at 64.96% (down 80.0% YoY), while the FY2025 annual figure was 64.8%, down 161.0% from the prior year.
  • Gross Margin was 66.88% for Q1 2026 at Bio-Techne, up from 64.65% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 8979.75% in Q3 2022 to a low of 62.72% in Q2 2025.
  • Historically, Gross Margin has averaged 590.86% across 5 years, with a median of 66.88% in 2026.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 891340 bps in 2022, then slumped 891288 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 67.52% in 2022, then fell by 4 bps to 64.78% in 2023, then gained by 1 bps to 65.27% in 2024, then fell by 1 bps to 64.65% in 2025, then advanced by 3 bps to 66.88% in 2026.
  • The last three Gross Margin figures came in at 66.88% (Q1 2026), 64.65% (Q4 2025), and 65.65% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 79.04%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 86.85%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 66.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 66.88%
Dec 31, 2025 64.65%
Sep 30, 2025 65.65%
Jun 30, 2025 62.72%
Mar 31, 2025 67.86%
Dec 31, 2024 65.27%
Sep 30, 2024 63.23%
Jun 30, 2024 66.43%
Mar 31, 2024 67.43%
Dec 31, 2023 64.78%
Sep 30, 2023 66.87%
Jun 30, 2023 67.93%
Mar 31, 2023 68.73%
Dec 31, 2022 67.52%
Sep 30, 2022 8,979.75%
Jun 30, 2022 69.51%
Mar 31, 2022 69.38%
Dec 31, 2021 68.22%
Sep 30, 2021 66.35%
Jun 30, 2021 67.92%